Olympus Biotech Corporation: Clinical Trials

7 trials sponsored by Olympus Biotech Corporation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 4 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4
Phase 32Completed 2

Follow Olympus Biotech Corporation: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin
Phase 3CompletedOlympus Biotech Corporation2072010-12-012014-08-05
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
Trafermin 0.01% spray - Diabetic Foot Ulcer of Neuropathic Origin
Phase 3CompletedOlympus Biotech Corporation2012010-11-012014-08-05
Study of OP-1 Putty in Uninstrumented Posterolateral Fusions
Degenerative Lumbar Spondylolisthesis
CompletedOlympus Biotech Corporation2022007-05-012011-06-10
A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal System
TLIF with a PEEK Spacer System and XIA Spinal System - Degenerative Disc Disease
Not applicableCompletedOlympus Biotech Corporation302007-02-012014-02-05
OP-1 Putty for Posterolateral Fusions
Spinal fusion - Degenerative Lumbar Spondylolisthesis
Not applicableCompletedOlympus Biotech Corporation3362001-10-012011-06-10
A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions
Use of OP-1 Putty in Uninstrumented posterolateral fusion - Degenerative Lumbar Spondylolisthesis
Not applicableCompletedOlympus Biotech Corporation481999-06-012011-06-10
OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions
Surgical implantation of OP-1 device or autograft bone graft material - Tibial Nonunions
Not applicableCompletedOlympus Biotech Corporation1221992-02-012011-06-10

Conditions studied

Intervertebral Disc Degeneration (4)  ·  Diabetic Foot (2)  ·  Wounds and Injuries (2)

Interventions

trafermin (2)  ·  Spinal Fusion (1)

Countries

United States (5)  ·  Canada (2)  ·  Hungary (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Sweden (1)

Top investigators

Jean-Charles Kerihuel, MD (2)